Page last updated: 2024-11-04

sumatriptan and Benign Intracranial Hypertension

sumatriptan has been researched along with Benign Intracranial Hypertension in 2 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mathew, NT1
Ravishankar, K1
Sanin, LC1
Nilsson, F1
Nilsson, T1
Edvinsson, L1
Rosén, I1
Björkman, S1
Messeter, K1
Nordström, CH1

Other Studies

2 other studies available for sumatriptan and Benign Intracranial Hypertension

ArticleYear
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
    Neurology, 1996, Volume: 46, Issue:5

    Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie

1996
Sumatriptan-induced cerebral vasoconstriction as treatment of experimental intracranial hypertension.
    Acta anaesthesiologica Scandinavica, 1996, Volume: 40, Issue:5

    Topics: Animals; Cerebral Arteries; Cerebral Veins; Cerebrovascular Circulation; In Vitro Techniques; Pseudo

1996